News
Business
Economy
Politics
Technology
Environment
Search
Thursday, October 17, 2024
No menu items!
News
Business
Economy
Politics
Technology
Environment
Search
Home
Eisai, Biogen’s Alzheimer’s drug price should not dent demand – analysts
FILE PHOTO: A sign marks a Biogen facility in Massachusetts
FILE PHOTO: A sign marks a Biogen facility in Massachusetts
FILE PHOTO: A sign marks a Biogen facility in Cambridge, Massachusetts, U.S. January 26, 2017. REUTERS/Brian Snyder
- Advertisment -
Most Read
Apple launches new iPad mini with AI features
October 15, 2024
China may raise $850 billion in new debt over three years to spur growth, says report
October 15, 2024
Under fire, Trump contends economic policies won’t boost federal debt
October 15, 2024
Intel, AMD team up to confront rising challenge from Arm
October 15, 2024
We use cookies to ensure that we give you the best experience on our website.
Ok
